Maja Hojnik

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler et al. · The Lancet · 2019 · 214 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves

Lea Ziporen, Iris Goldberg, Michael Arad et al. · Lupus · 1996 · 167 citations

Medicine, Immunology, Pathology +17

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52

Josef S Smolen, Philip J. Mease, Hasan Tahir et al. · Annals of the Rheumatic Diseases · 2020 · 85 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Anticardiolipin Antibodies in Infections are Heterogenous in Their Dependency on β 2-Glycoprotein I: Analysis of Anticardiolipin Antibodies in Leprosy

Maja Hojnik, Boris Gilburd, Lea Ziporen et al. · Lupus · 1994 · 75 citations

Life Sciences, Immunology, Infectious Diseases +13

Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding.

Jacob George, Boris Gilburd, Maja Hojnik et al. · PubMed · 1998 · 72 citations

Life Sciences, Biochemistry, Immunology +17